| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 04/30/1991 | CA1283606C Phospholipid-containing products, their preparation and their use |
| 04/30/1991 | CA1283605C Pharmaceutical composition for suppository containing buprenorphine |
| 04/30/1991 | CA1283604C2 Dehydrated liposomes |
| 04/30/1991 | CA1283602C Pre-s gene coded peptide hepatitis b immunogens, vaccines, diagnostics, and synthetic lipid vesicle carriers |
| 04/28/1991 | CA2028633A1 Sustained-release preparation of basic medical agent hydrochloride |
| 04/28/1991 | CA2028536A1 Injectable parasiticidal composition |
| 04/28/1991 | CA2027677A1 Protection of a food, cosmetic or pharmaceutical against oxidation |
| 04/25/1991 | DE3935257A1 Liposome(s) contg. fluorescent marker and coupled to antibody - useful as diagnostic reagent and for targetted delivery of therapeutic agent for treating cancer, malaria etc. |
| 04/25/1991 | CA2028307A1 Cosmetic and pharmaceutic compositions containing reticulated poly-.beta-alanine spheres impregnated with a lipophilic substance |
| 04/24/1991 | EP0424168A1 Polymer complexes of a sugar response type |
| 04/24/1991 | EP0424043A1 Liquid aqueous ophthalmic composition undergoing liquid-gel phase transition |
| 04/24/1991 | EP0424042A1 Non-solid ophthalmic composition and process for preparing the said composition |
| 04/24/1991 | EP0423980A1 Stem cell factor |
| 04/24/1991 | EP0423818A1 Arylsulfatase |
| 04/24/1991 | EP0423748A1 Stabilized pharmaceutical composition and its production |
| 04/24/1991 | EP0423747A2 Glycosyl-etoposide prodrugs, process for their preparation and their use in combination with functionalised tumour-specific enzyme conjugates |
| 04/24/1991 | EP0423541A2 Polytetrafluoroethylene therapeutic articles |
| 04/24/1991 | EP0423484A1 Tablet with sustained release |
| 04/24/1991 | CA2028256A1 Multiple layer transdermal drug administration system |
| 04/24/1991 | CA2027865A1 Sustained release elements |
| 04/23/1991 | US5010176 Malonate linker |
| 04/23/1991 | US5010167 Poly(amide-and imide-co-anhydride) for biological application |
| 04/23/1991 | US5010110 Water activated solid emolient product and preparation thereof |
| 04/23/1991 | US5010069 Stable liquid form of 5-aminosalicylic acid |
| 04/23/1991 | US5010065 Cyclodextrin clathrates of 5-cyanoprostacyclin derivatives and their use as pharmaceutical agents |
| 04/23/1991 | US5010064 Anticoagulants |
| 04/23/1991 | US5010061 Guar flour |
| 04/23/1991 | US5009895 Sustained release with high and low viscosity HPMC |
| 04/23/1991 | US5009890 Burn treatment product |
| 04/23/1991 | CA1283497C Polymer-treated ion exchange resins |
| 04/23/1991 | CA1283360C Process for the preparation of a viscosity-stable antacid composition |
| 04/23/1991 | CA1283359C Compositions of neocarzinostatin derivative for non-injection administration |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/21/1991 | CA2028086A1 Glycosyl-etoposide prodrugs, a process for the preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates |
| 04/20/1991 | WO1991005736A1 Hydrophilic polymer-silicate mineral composite and its use |
| 04/19/1991 | WO1991005547A1 Direct compression carrier composition |
| 04/19/1991 | CA2066677A1 Direct compression carrier composition |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004988A1 Polyglucuronic acid, process for preparing polyglucuronic acid and use of polyglucuronic acid |
| 04/18/1991 | WO1991004753A1 Conjugates of antisense oligonucleotides and therapeutic uses thereof |
| 04/18/1991 | WO1991004743A1 Stabilized aqueous formulations of small peptides |
| 04/18/1991 | WO1991004741A1 Composition for the treatment of progressive myopia |
| 04/18/1991 | WO1991004739A1 Use of prostacyclin derivatives against metastases |
| 04/18/1991 | WO1991004734A1 Pharmaceutical compositions containing 4,6-tioxoheptanoic acid or its derivatives |
| 04/18/1991 | WO1991004730A1 Composition and methods for the stabilization of materials dispersed onto applicators |
| 04/18/1991 | WO1991004727A1 Device for oral administration of an active principle for preventive treatment of caries in babies |
| 04/18/1991 | WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | CA2027607A1 Sustained release ophthalmic vehicle |
| 04/17/1991 | EP0422681A1 Collagen containing ophthalmic formulation |
| 04/17/1991 | EP0422497A2 Inclusion complexes with silybinin, their preparation and pharmaceutical compositions containing them |
| 04/17/1991 | EP0422186A1 Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m |
| 04/17/1991 | EP0422043A1 Bispecific antibodies |
| 04/17/1991 | EP0270632A4 Body powder in liquid form, body powder containing active ingredients and method of preparing thereof |
| 04/17/1991 | CA2267658A1 Use of stem cell factor polypeptide to stimulate growth of epithelial cells |
| 04/17/1991 | CA2267643A1 Use of stem cell factor polypeptide as an anti-hematopoietic disorder agent |
| 04/17/1991 | CA2267626A1 Use of stem cell factor polypeptide to stimulate growth of stromal cells |
| 04/17/1991 | CA2027684A1 Polytetrafluoroethylene therapeutic articles |
| 04/17/1991 | CA2025453A1 Pressing having sustained release of active compound |
| 04/16/1991 | US5008406 Hemiacetal compounds and the applications thereof |
| 04/16/1991 | US5008386 Methylated cyclodextrin type compounds and process for preparing same |
| 04/16/1991 | US5008254 Sugar beet pectins and their use in comestibles |
| 04/16/1991 | US5008116 Immobilized antigen |
| 04/16/1991 | US5008113 Irradiation of cellulose derivatives for high strength, whiteness and clearness |
| 04/16/1991 | US5008108 Compositions utilizing an exocellular polysaccharide isolated from Zoogloea ramigera |
| 04/16/1991 | US5008106 Method for reducing the microbial content of surfaces with a microbiocidal, anhydrous complex of PVP-H2 O2 |
| 04/16/1991 | US5008038 As germicides and preservatives in cosmetics |
| 04/16/1991 | US5007790 Sustained-release oral drug dosage form |
| 04/16/1991 | CA1283052C Medicament depot |
| 04/16/1991 | CA1283047C Stabilized plasminogen activator precursor and method of producing the same |
| 04/16/1991 | CA1283046C Tumor necrosis factor formulation |
| 04/14/1991 | CA2027433A1 Collagen containing ophthalmic formulation |
| 04/12/1991 | WO1991006008A1 Method for purifying chelator conjugated compounds |
| 04/12/1991 | CA2069303A1 Method for purifying chelator conjugated compounds |
| 04/11/1991 | WO1991005806A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/11/1991 | DE4029747A1 Psoriasis treatment |
| 04/11/1991 | CA2067210A1 Interfacial condensation of bioactive compounds and the site-specific compounds and conjugates thereof |
| 04/10/1991 | EP0421825A1 Paracetamol solutions |
| 04/10/1991 | EP0421562A2 Use of prostacyclin analogs against metastases |
| 04/10/1991 | EP0421333A1 Tretinoin emulsified cream formulations of improved stability |
| 04/10/1991 | EP0421297A2 Injectable preparations containing cephalosporin medicament and the use thereof |
| 04/10/1991 | EP0420964A1 Lyophilized peptide formulations |
| 04/10/1991 | EP0420849A1 Use of sucralfate |
| 04/10/1991 | EP0277127B1 New drug preparation with controlled release of the active compound, and a method for the manufacture thereof |
| 04/10/1991 | CN1050504A Magnetic medicine carrier and its production method |
| 04/10/1991 | CN1050503A Stabilized leukocyte-interferons |
| 04/10/1991 | CN1050502A Topical preparation for treatment of aphthous ulcers and other lesions |
| 04/10/1991 | CN1050501A Injectable preparations containing cephalosporin medicament |
| 04/09/1991 | US5006652 Intermediates for antibody-vinca drug conjugates |
| 04/09/1991 | US5006648 Process for preparing partial polyol fatty acid esters |
| 04/09/1991 | US5006643 Process for preparing isothiocyanato functionalized metal complexes |
| 04/09/1991 | US5006595 Solubilization of complexes of water-insoluble organic compounds by aqueous solutions of polyvinylpyrrolidone |
| 04/09/1991 | US5006510 Antinociceptive for burningpain or hyperesthesia |
| 04/09/1991 | US5006509 Use of human growth hormone in treating topical ulcers |
| 04/09/1991 | US5006470 Diagnosis by detecting complex formed between monocloral antibody and melanoma antigen |
| 04/09/1991 | US5006345 Direct tableting auxiliary |
| 04/09/1991 | US5006343 Liposomes, alveolar surfactant protein |
| 04/09/1991 | US5006333 Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| 04/09/1991 | CA1282703C Stable injectable antiemetic compositions |